An interventional study of Peer support in Stroke, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-25.
Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Stroke by Hospices Civils de Lyon — 13 open to participants now, 14 under way, none of them phase 3. Stroke · Hospices Civils de Lyon.
Among the 40 studies in Stroke by Hospices Civils de Lyon, this one is the 15th largest by planned enrollment of the 26 interventional ones that give a count, is the only one that started in 2020, is one of 24 with no phase, reaches primary completion later than 7 of the 13 other live ones, and was the 24th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →13 of the 40 studies in Stroke by Hospices Civils de Lyon are open now, in 1 country. Recruiting first, the newest first:
Hospices Civils de Lyon · Sites in France
Ages 18–85
Hospices Civils de Lyon · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 65–100
Hospices Civils de Lyon · Sites in France
Ages 30–80
Hospices Civils de Lyon · Sites in France
Ages 18–100
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 1 started in 2020.
This study's planned enrollment of 40 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 50 across the 26 interventional studies, 348 across the 14 observational. Of the 22 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Hospices Civils de Lyon is the lead sponsor of 1,868 studies on the registry; 447 are open to participants now.
3 of the studies in Stroke by Hospices Civils de Lyon that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04197258Hospices Civils de LyonEvaluation of the Impact of an Individual Peer Support Intervention for Stroke Patients When Returning Home: a Mixed Methods Pilot Study | 2026-12-05 |
| NCT05874154Hospices Civils de LyonEvaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach | 2027-03-02 |
| NCT06306144Hospices Civils de LyonEarly-phase Telecare Programs for Minor Stroke | 2027-09-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 40 studies in Stroke by Hospices Civils de Lyon, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Going back home following a stroke is a key step for the patient and his or her relatives. Due to the brutality of stroke and increasingly shorter in-hospital lengths of stay, patients and their families must adapt quickly to the patient's new health functioning and the new caregiving and support role for family members.
Peer support could be an innovative and inexpensive approach to addressing these issues. Peer-helpers are patient-partners who put their experiential knowledge from life with the disease at the disposal of other patients to offer them social and emotional support in the management of the disease in connection with care, social and community structures. Group peer support programs face organizational challenges and fail to address the full range of patient needs for stroke home visits. Individualized and more flexible support could better meet the needs of patients. Our hypothesis is that individual peer support improves quality of life and patient empowerment during the discharge period compared to usual practice.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
For 6 months after discharge, patients in the intervention group will benefit from peer support by a trained patient (number and frequency of contacts defined according to the patient's needs). The intervention aims to improve the patient's ability to manage his or her situation and meet his or her needs upon discharge at home, including identifying and seeking for the necessary health or social resources
Other: Peer support
Patients included in the control group before intervention will receive the usual practices. As part of the study, they will be contacted for data collection 6 months after the transition to home by a clinical research associate.
The intervention studied is the psycho-social support by a peer-helper to the patients and their main informal caregiver during the return home following a stay in rehabilitation center for a stroke. Peer support intervention will be based on evidence, Bandura's social learning and social support theory, and the results of our ongoing study of the needs of patients and their caregivers as a result of returning home (Stroke69). It will include a meeting before the discharge and a regular follow-up for 6 months (face-to-face meetings, virtual or by phone), adapted to the needs of the patient and his caregiver, taking into account the social environment and in connection with the devices existing sanitary and social.
Feasibility measure
The feasibility of the intervention will be evaluated as success with a combined criteria including: * Recruitment and training of 2 peer helpers, * Support offered to 20 patients by the peer helpers during the intervention period defined by at least one meeting before and one contact after discharge per patient included in period after, * Good acceptability by patients, carers and peer helpers. These data will be collected by a qualitative approach associating semi-directive interviews, focus groups and participant observation.
Time frame: 6 months
Quality of life between the discharge from hospital and 6 months
Evolution of the dimensions of the SIS at hospital discharge and 6 months: force dimension
Time frame: 6 months
Quality of life between the discharge from hospital and 6 months
Evolution of the dimensions of the SIS at hospital discharge and 6 months: manual function
Time frame: 6 months
Quality of life between the discharge from hospital and 6 months
Evolution of the dimensions of the SIS at hospital discharge and 6 months: AVQ/AVD
Time frame: 6 months
Quality of life between the discharge from hospital and 6 months
Evolution of the dimensions of the SIS at hospital discharge and 6 months: Mobility
Time frame: 6 months
Quality of life between the discharge from hospital and 6 months
Evolution of the dimensions of the SIS at hospital discharge and 6 months: Communication and Emotions
Time frame: 6 months
Quality of life between the discharge from hospital and 6 months
Evolution of the dimensions of the SIS at hospital discharge and 6 months: Memory and thinking
Time frame: 6 months
Quality of life between the discharge from hospital and 6 months
Evolution of the dimensions of the SIS at hospital discharge and 6 months: global recovery
Time frame: 6 months
Anxiety and depression scores between discharge and 6 months
Evolution of anxiety and depression scores between discharge and 6 months after discharge, measured by the Hospital Anxiety and Depression scale (HADS) score
Time frame: 6 months
Patient activation Measure
Evolution of patient activation between discharge and 6 months after discharge, measured by the Patient activation Measure (PAM) score
Time frame: 6 months
Disability
proportion of patients with disabilities at 6 months evaluated by the Modified Rankin Scale (no disability corresponding to mRs\<3)
Time frame: 6 months
Adherence
proportion of adherent patients at 6 months evaluated by the Medication Adherence Rating Scale (MARS)
Time frame: 6 months
Human, material and financial assistance provided at home
Human, material and financial assistance provided at home collected by interviewing the patient
Time frame: 6 months
Satisfaction measure
Perceived satisfaction of the support received on during the discharge period will be collected by interviewing the patient
Time frame: 6 months
Caregiver burden
Evolution of caregiver burden between discharge and 6 months after discharge, measured by the Zarit burden scale
Time frame: 6 months
Caregiver satisfaction
Perceived caregiver satisfaction of the support during the patient's discharge period will be collected by interviewing caregiver
Time frame: 6 months
Started Oct 2020 (actual). Primary completion is estimated for Dec 2026, 73 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 73 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.